Asian Paints

2579.9 11.30

Cipla

1553.4 -24.40

Eicher Motors

6580.5 155.50

Nestle India

1208.5 -4.10

Grasim Inds

2804 -5.80

Hero Motocorp

5363 12.00

Hindalco Inds.

743.8 4.75

Hind. Unilever

2633.4 -33.20

ITC

407.35 -8.55

Trent

5528.5 -0.50

Larsen & Toubro

3553.6 -39.00

M & M

3561.3 79.80

Reliance Industr

1375 15.70

Tata Consumer

1072.4 1.30

Tata Motors

691.7 4.20

Tata Steel

167.68 0.87

Wipro

243.67 -1.30

Apollo Hospitals

7804.5 -95.50

Dr Reddy's Labs

1268.1 15.10

Titan Company

3665.3 -25.80

SBI

806.6 -2.80

Shriram Finance

592.5 6.70

Bharat Electron

370.8 -1.70

Kotak Mah. Bank

1945.5 -4.20

Infosys

1444.6 -18.40

Bajaj Finance

937.6 2.85

Adani Enterp.

2281.4 2.60

Sun Pharma.Inds.

1593.6 11.30

JSW Steel

1073.1 0.70

HDFC Bank

963.4 2.15

TCS

3048.3 -47.40

ICICI Bank

1402.8 -2.70

Power Grid Corpn

285.35 3.55

Maruti Suzuki

14895 233.00

IndusInd Bank

757.05 2.20

Axis Bank

1055.9 5.50

HCL Technologies

1419 -24.30

O N G C

234.13 -1.59

NTPC

328.7 -1.35

Coal India

392.65 1.20

Bharti Airtel

1895.3 14.90

Tech Mahindra

1477.9 -22.50

Adani Ports

1321.8 -6.40

HDFC Life Insur.

759.55 5.30

SBI Life Insuran

1805.3 14.20

UltraTech Cem.

12601 -50.00

Bajaj Auto

9084.5 13.50

Bajaj Finserv

2014.4 12.20

Eternal Ltd

329.15 2.90

IPO-Synopsis
Alivus Life Sciences Ltd
Initial public offer of 21,022,222 equity shares of face value of Rs. 2 each ("equity shares") of Glenmark Life Sciences Limited ("Company" or "Issuer") for cash at a price of Rs. 720 per equity share (including a share premium of Rs. 718 per equity share) aggregating to Rs. 1513.60 crores (the "offer") comprising a fresh issue of 14,722,222 equity shares aggregating to Rs. 1060 crores (the "fresh issue") and an offer for sale of up to 6,300,000 equity shares by Glenmark Pharmaceuticals Limited ("Promoter Selling Shareholder") and such equity shares, The "offered shares") aggregating to Rs. 453.60 crores (The "offer for sale"). The offer shall constitute 17.16% of the post-offer paid-up equity share capital of the company. The face value of equity shares is Rs. 2 each. Offer Price : Rs. 720 per Equity Share of face value of Rs. 2 each. Anchor Investor offer price: Rs. 720 per Equity share. The Offer Price is 360 times the face value.
Issue
Opens On Closes On
27-Jul-21 29-Jul-21
Money Payable On
Application Allotment
720.00 0.00
Minimum Application for shares in Nos : 20 Further Multiples of : 20
Cr Lead Managers to the Issue
Project Cost (.Cr) 1060.00 BOB Capital Markets Ltd
Project Financed through Current Offer (.Cr) 1513.60  
Post Issue Equity Share Capital (.Cr) 24.51
Issue Price () 720.00
Projects
Payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company pursuant to the Business Purchase agreement
Funding capital expenditure requirements
General corporate purposes
Promoted By
Glenmark Pharmaceuticals Ltd
Listing At
BSE
NSE
Registrar to the Issue
No Data Available

DJIA 45627.16
334.92 0.74%
S&P 500 6520.86
51.60 0.80%
HANG SENG 25417.99
359.47 1.43%
NIKKEI 225 42984.31
404.04 0.95%
FTSE 100 9208.21
-8.66 -0.09%
NIFTY 24741.00
6.70 0.03%
×
Ask Your Question
close
refresh